Latest Breaking News On - Bahrain national health regulatory authority - Page 1 : comparemela.com

Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA

Emmaus Life Sciences Inc receives approval to market Endari in Bahrain

Emmaus Life Sciences Inc (OTCQX:EMMA) announced that it has received a Medicine Registration Certificate (DRN-10164/23) from the Bahrain National Health.

Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA

/PRNewswire/ Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease treatment, announced today that it has received a Medicine.

Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA

TORRANCE, Calif., May 31, 2023 /PRNewswire/  Emmaus Life Sciences, Inc. , a leader in sickle cell disease treatment, announced today that it has received a Medicine Registration. | June 7, 2023

Valneva's Covid-19 vaccine hits another bump with EMA request for further data

The latest request marks the third time the French company was questioned about its Covid-19 vaccine by the European agency.